Literature DB >> 11869411

Cardiac involvement in infantile Sandhoff disease.

P Venugopalan1, S N Joshi.   

Abstract

An 18-month-old boy with enzyme assay-confirmed infantile Sandhoff disease (MIM 268800) is reported. Besides the classical neurological features, this patient exhibited severe mitral regurgitation secondary to mitral valve prolapse and mild aortic regurgitation from aortic valve prolapse. He also had asymmetric hypertrophy of the interventricular septum without left ventricular outflow tract obstruction.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11869411     DOI: 10.1046/j.1440-1754.2002.00765.x

Source DB:  PubMed          Journal:  J Paediatr Child Health        ISSN: 1034-4810            Impact factor:   1.954


  5 in total

1.  Metabolomics profiling reveals profound metabolic impairments in mice and patients with Sandhoff disease.

Authors:  Li Ou; Michael J Przybilla; Chester B Whitley
Journal:  Mol Genet Metab       Date:  2018-09-14       Impact factor: 4.797

2.  Effects of gene therapy on cardiovascular symptoms of lysosomal storage diseases.

Authors:  Edina Poletto; Gabriela Pasqualim; Roberto Giugliani; Ursula Matte; Guilherme Baldo
Journal:  Genet Mol Biol       Date:  2019-05-23       Impact factor: 1.771

3.  Infantile onset Sandhoff disease: clinical manifestation and a novel common mutation in Thai patients.

Authors:  Thipwimol Tim-Aroon; Khunton Wichajarn; Kamornwan Katanyuwong; Pranoot Tanpaiboon; Nithiwat Vatanavicharn; Kullasate Sakpichaisakul; Arthaporn Kongkrapan; Jakris Eu-Ahsunthornwattana; Supranee Thongpradit; Kanya Moolsuwan; Nusara Satproedprai; Surakameth Mahasirimongkol; Tassanee Lerksuthirat; Bhoom Suktitipat; Natini Jinawath; Duangrurdee Wattanasirichaigoon
Journal:  BMC Pediatr       Date:  2021-01-07       Impact factor: 2.125

4.  Infantile Sandhoff disease with ventricular septal defect: a case report.

Authors:  Jamal Khaled Sahyouni; Luma Bassam Mahmoud Odeh; Fahad Mulla; Sana Junaid; Subhranshu Sekhar Kar; Naheel Mohammad Jumah Al Boot Almarri
Journal:  J Med Case Rep       Date:  2022-08-25

Review 5.  GM2 Gangliosidoses: Clinical Features, Pathophysiological Aspects, and Current Therapies.

Authors:  Andrés Felipe Leal; Eliana Benincore-Flórez; Daniela Solano-Galarza; Rafael Guillermo Garzón Jaramillo; Olga Yaneth Echeverri-Peña; Diego A Suarez; Carlos Javier Alméciga-Díaz; Angela Johana Espejo-Mojica
Journal:  Int J Mol Sci       Date:  2020-08-27       Impact factor: 5.923

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.